立体定向肝脏放疗中自主深吸气屏气期间的分次内基准标记位置变化
研究10例肝转移患者行立体定向体部放疗,在视觉引导下自主深吸气屏气,评估基准标记分次内位置变化。三次屏气CT间标记中位差异0.3 cm,分次前CBCT与分次后CBCT间中位差异0.3 cm;4例患者平面kV图像显示头脚方向分次内变化最大0.7–1.3 cm,单次屏气内可达1.0 cm。结论认为治疗前屏气CT稳定性检查不足以保证每分次稳定性,需实时监测肿瘤或可靠内替代物。
要点
- 单次深吸气屏气内基准标记位置差异可达1.0 cm,即使使用窄外部门控窗和视觉反馈。
- 治疗前深吸气屏气CT稳定性检查不足以保证每分次稳定性。
- 分次前与分次后CBCT的标记位置差异并不总能完全反映分次内变化幅度。
核心结论
- 尽管使用窄外部门控窗和视觉反馈,单次深吸气屏气期间仍观察到基准标记位置差异达1.0 cm。
- 治疗前深吸气屏气CT上的稳定性检查不足以保证每分次稳定性。
- 分次前与分次后CBCT上的标记位置差异并不总能揭示分次内变化的全部幅度。
研究设计与样本
- 研究纳入10例植入基准标记的肝转移患者,行立体定向体部放疗。
- 采用视觉引导的呼吸训练,确保患者在SBRT成像和照射时能舒适地自主深吸气屏气。
- 采集3次深吸气屏气CT用于治疗计划;三个治疗分次中每次采集治疗前和治疗后CBCT。
- 对10例患者中的4例,在治疗分次期间采集平面2D kV图像以评估每分次标记位置。
诊断标准与关键数值
- 三次深吸气屏气CT之间标记位置的中位差异为0.3 cm(范围0.0–0.9 cm)。
- 治疗前与治疗后CBCT之间标记位置的中位差异为0.3 cm(范围0.1–1.4 cm)。
- 4例患者平面kV图像上头脚方向分次内标记位置最大变化为0.7–1.3 cm,单次深吸气屏气内可达1.0 cm。
临床应用与阅片要点
- 在自主深吸气屏气下实施肝脏SBRT时,为提高治疗准确性,有必要对肿瘤或可靠的内替代物进行实时监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate intrafractional fiducial marker position variations during stereotactic body radiotherapy (SBRT) in patients treated for liver metastases in visually guided, voluntary deep inspiration breath-hold (DIBH).
METHODS: 10 patients with implanted fiducial markers were studied. Respiratory coaching with visual guidance was used to ensure comfortable voluntary breath-holds for SBRT imaging and delivery. Three DIBH CTs were acquired for treatment planning. Pre- and post-treatment CBCTs were acquired for each of the three treatment fractions. Per-fraction marker position was evaluated on planar 2D kV images acquired during treatment fractions for 4 of the 10 patients.
RESULTS: The median difference in marker position was 0.3 cm (range, 0.0-0.9 cm) between the three DIBH CTs and 0.3 cm (range, 0.1 to 1.4 cm) between pre- and post-treatment CBCTs. The maximum intrafractional variation in marker position in craniocaudal (CC) direction on planar kV images was 0.7 to 1.3 cm and up to 1.0 cm during a single DIBH.
CONCLUSION: Difference in marker position of up to 1.0 cm was observed during a single DIBH despite use of narrow external gating window and visual feedback. Stability examination on pre-treatment DIBH CTs was not sufficient to guarantee per-fraction stability. Evaluation of differences in marker position on pre- and post-treatment CBCT did not always reveal the full magnitude of the intrafractional variation.
ADVANCES IN KNOWLEDGE: To increase treatment accuracy, it is necessary to apply real-time monitoring of the tumour or a reliable internal surrogate when delivering liver SBRT in voluntary DIBH.
引用
- Stick LB, Vogelius IR, Risum S, et al. Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold. Br J Radiol. 2020. PMID: 32915653. doi:10.1259/bjr.20200859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。